跳至主要内容
临床试验/TCTR20210604002
TCTR20210604002尚未招募不适用

Outcome of treatment with Triheptanoin in pediatric patients with long chain fatty acid oxidation disorders (LCFAODs) at Queen Sirikit National Institute of Child Health.

/A0 个研究点目标入组 2 人开始时间: 2021年6月4日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
2

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 Weeks 至 15 Years(—)
性别
All

入选标准

  • Patient with diagnosis of long
  • chain fatty acid oxidation disorders (LCFAODs)

排除标准

  • can not continue treatment until the end of research

研究者

发起方
/A

相似试验

已完成
2 期
An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency SyndromeGlucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)
NCT02036853Adrian Lacy20
进行中(未招募)
1 期
The effect of Triheptanoin in adults with McArdle Disease (Glycogen Storage Disease Type V)McArdle Disease Also called: Glycogen Storage Disease Type V or Myophosphorylase DeficiencyMedDRA version: 19.0Level: LLTClassification code 10026970Term: McArdles diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 19.0Level: LLTClassification code 10026969Term: McArdle's diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 19.0Level: PTClassification code 10018462Term: Glycogen storage disease type VSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2014-003644-12-DKeuromuscular Research Unit, Rigshospitalet28
招募中
2 期
TiNT: Trametinib in Neurofibromatosis type 1 associated tumoursPlexiform neurofibromatosisOptic pathway gliomaCancer - Children's - BrainCancer - Children's - OtherHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersNeurological - Other neurological disordersNeurofibromatosis type 1
ACTRN12620001229965Australian and New Zealand Children's Haematology/Oncology Group120
尚未招募
不适用
Comparison of drug effect with placebo in children with abnormal movements
CTRI/2019/02/017481Abhishek S
已完成
2 期
Propranolol in treatment of hemangiomaHemangioma.Hemangioma, any site
IRCT2014041817325N1Ardabil University of Medical Sciences20